"Breast cancer therapy" trang 1 - tải miễn phí từ tailieuXANH
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4

FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4
14    62    0
Investigating confounders of the association between survival and adjuvant radiation therapy after breast conserving surgery in a sample of elderly breast Cancer patients in Appalachia

Investigating confounders of the association between survival and adjuvant radiation therapy after breast conserving surgery in a sample of elderly breast Cancer patients in Appalachia
11    59    0
Assessment of preoperative axillary nodal disease burden: Breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy

Assessment of preoperative axillary nodal disease burden: Breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy
11    215    1
Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: Results of a randomized study - SAKK 22/99

Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: Results of a randomized study - SAKK 22/99
9    64    0
Effect of neoadjuvant therapy on breast cancer biomarker profile

Effect of neoadjuvant therapy on breast cancer biomarker profile
9    116    0
Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: A multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators

Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: A multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators
11    84    0
Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: A systematic review

Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: A systematic review
13    74    0
Androgen receptor in advanced breast cancer: Is it useful to predict the efficacy of anti-estrogen therapy

Androgen receptor in advanced breast cancer: Is it useful to predict the efficacy of anti-estrogen therapy
8    99    0
Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: Study protocol of a randomized controlled trial

Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: Study protocol of a randomized controlled trial
10    63    0
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: A retrospective single-center study

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: A retrospective single-center study
7    176    2
Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer

Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer
12    115    0
A multiple breast cancer stem cell model to predict recurrence of T1–3, N0 breast cancer

A multiple breast cancer stem cell model to predict recurrence of T1–3, N0 breast cancer
11    114    0
Overdiagnosis of breast cancer in the norwegian breast cancer screening program estimated by the norwegian women and cancer cohort study

Overdiagnosis of breast cancer in the norwegian breast cancer screening program estimated by the norwegian women and cancer cohort study
9    75    0
Cost-effectiveness of different surgical treatment approaches for early breast cancer: A retrospective matched cohort study from China

Cost-effectiveness of different surgical treatment approaches for early breast cancer: A retrospective matched cohort study from China
12    55    1
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors

Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
13    68    0
Methylene blue photodynamic therapy induces selective and massive cell death in human breast cancer cells

Methylene blue photodynamic therapy induces selective and massive cell death in human breast cancer cells
15    52    0
Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancerrelated fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design

Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancerrelated fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design
13    48    0
Roles of neutrophil/lymphocyte ratio in prognosis and in differentiation of potential beneficiaries in HER2-positive breast cancer with trastuzumab therapy

Roles of neutrophil/lymphocyte ratio in prognosis and in differentiation of potential beneficiaries in HER2-positive breast cancer with trastuzumab therapy
8    75    0
The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients

The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients
8    49    0
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer

Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer
10    59    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.